To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed
Menée en Colombie Britannique à l'aide d'un modèle de microsimulation, cette étude estime l'évolution de l'incidence du cancer du col utérin sur la période 2023-2050 en fonction de plusieurs stratégies de dépistage basées sur le taux de couverture vaccinale contre le papillomavirus humain, le taux de participation au programme de dépistage, le taux de suivi et l'utilisation du test HPV
Cervical cancer is almost entirely preventable and is curable if detected early. In related research, Pataky and colleagues model strategies for the elimination of cervical cancer in British Columbia and find that the greatest gains would come from increasing self-sampling uptake among underscreened populations. Increasing uptake in hard-to-reach populations could be achieved by reducing barriers to accessing self-testing, or self-sampling. Guidelines from the World Health Organization published in 2022 recommend that self-sampling for human papillomavirus (HPV) be included in cervical cancer screening.2 The Canadian Partnership Against Cancer’s 2019 action plan to eliminate cervical cancer in Canada stated this as an immediate goal.3 British Columbia has led Canadian jurisdictions by integrating self-sampling as an option in its screening program as of January 2024. That cervical cancer accounts for 1.3% of all new female cancers and 1.1% of all female cancer deaths in Canada, yet is preventable, should prompt all health systems in Canada to fund self-sampling without delay
Canadian Medical Association Journal , éditorial en libre accès, 2023